STRATEC SE NA O.N. | 136.80 / +1.03% |
Date/Time | 01/25 / 09:49 |
Chg. / Chg.(%) | 1.40 / +1.03% |
Bid | 136.20 / 191 |
Ask | 137.20 / 196 |
Open | 136.60 |
Previous Close | 135.40 |
High | 137.00 |
Low | 136.20 |
Volume [EUR] | 111,458.40 |
Volume [Units] | 815 |
Price fixings | 25 |
ISIN | DE000STRA555 |
Security | SBS |
Exchange | Xetra |
Type | Stock |
Exchange | Last | Volume | |
---|---|---|---|
Xetra | 136.80 | ![]() |
815 |
TradeGate | 136.20 | ![]() |
601 |
Cboe Europe .. | 136.80 | ![]() |
166 |
Düsseldorf | 137.00 | ![]() |
89 |
Turquoise | 137.20 | ![]() |
31 |
gettex | 136.800 | ![]() |
8 |
Stuttgart | 136.400 | ![]() |
5 |
London Inter.. | 136.60 | ![]() |
2 |
München | 134.00 | ![]() |
0 |
Hannover | 134.00 | ![]() |
0 |
Hamburg | 134.00 | ![]() |
0 |
Berlin | 136.80 | ![]() |
0 |
Frankfurt | 134.0000 | ![]() |
0 |
Lang & Schwa.. | 136.20 | ![]() |
|
Cboe Europe .. | 123.20 | 87 | |
Cboe Europe .. | 125.00 | 45 | |
Nasdaq Other.. | 72.9551 | 300 | |
EUREX | Options |
News
- Global Cell Free DNA Isolation and Extraction Market, 2026 - Focus on 25 Country Analysis, Competitive Landscape, Applications (NIPT, Oncology, etc.), Product and Platform
06/21/2018 / 10:06 - GlobeNewswire - $4.5 Billion Liquid Biopsy Research Tools, Services and Diagnostics Markets, 2022
10/23/2017 / 11:36 - GlobeNewswire - Curetis Announces its Initial Public Offering on Euronext in Amsterdam and Euronext in Brussels
10/28/2015 / 08:00 - GlobeNewswire - Cornerstones of our strategy redefined
10/23/2008 / 07:00 - GlobeNewswire - Hugin Ad hoc announcement according to § 15 WpHG: Misc. business figure: STRATEC Biomedical Systems AG: STRATEC clearly exceeds earnings for overall previous year after only nine months
10/24/2006 / 11:39 - GlobeNewswire